Xcout Intel
Humane Genomics
Humane Genomics is a New York-based life sciences company that develops targeted viral therapies and technologies for cancer treatment.
Subscribe to see Humane Genomics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Humane Genomics at a glance
Humane Genomics is a deeptech company headquartered in United States. Its most recent funding round, Seed, raised $4M in February 2025. Xcout tracks 2 named people at Humane Genomics, including Chad Moles (Chief Science Officer).
Humane Genomics leadership
- Chad MolesChief Science Officer
- Andrew Hesselco-founder
Humane Genomics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $4M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Humane Genomics competitors
A few of Humane Genomics's closest competitors — see the full list of competitors and alternatives →
East Ocyon Bio Private Limited is a leading cell and gene therapy company headquartered in India that is advancing cellular immunotherapy and developing treatments such as CAR-NK, CRISPR, and Gamma Delta T-cell therapies for cancer.
Headquartered in South San Francisco, California, Chimera Bioengineering is a privately held biotechnology company focused on developing advanced cellular engineering technologies for cancer therapies.
Avenzo Therapeutics, Inc. is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to developing next-generation oncology treatments.
Zumutor Biologics is an immuno-oncology company incorporated in the USA, with its primary office in Cambridge, Massachusetts. The company is a leading firm in the space of targeted NK cell therapeutics and utilizes proprietary naïve human phage/yeast display technology.
Get Humane Genomics's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Humane Genomics? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Humane Genomics in Xcout Intel
- 2 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access